Sumitomo Mitsui Trust Holdings, Inc. Acadia Pharmaceuticals Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$25.02 - $54.99 $371,547 - $816,601	-14,850 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$36.42 - $57.0 $1.56 Million - $2.44 Million	-42,890 Reduced 74.28%	14,850 $613,000
Q2 2020 Jul 27, 2020	BUY	$39.26 - $52.73 $2.27 Million - $3.04 Million	57,740 New	57,740 $2.8 Million
Q1 2020 Apr 27, 2020	SELL	$31.65 - $46.87 $1.04 Million - $1.54 Million	-32,929 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$36.21 - $51.4 $1.19 Million - $1.69 Million	32,929 New	32,929 $1.41 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.